- Posted August 01, 2014
- Tweet This | Share on Facebook
State inmates may get costly hepatitis C drug
LANSING (AP) - A new hepatitis C treatment that costs $1,000 pill is expected to be available to Michigan inmates.
The Detroit News reports the Michigan Department of Corrections 2015 budget, which takes effect Oct. 1, includes $4.4 million for the drug, which holds promise for a cure for the liver-damaging disease.
Corrections spokesman Russ Marlan says pills will be "targeted to the serious cases where the traditional hepatitis C drugs have been ineffective."
Meanwhile, Michigan Department of Community Health spokeswoman Angela Minicuci says the drug is being provided on a "case by case" basis to non-inmate Medicaid patients.
Illinois and other states are restricting Sovaldi's use, according to a July 23 earnings call held by the drug's maker, California-based Gilead Sciences Inc. The Food and Drug Administration approved Sovaldi in December.
Published: Fri, Aug 01, 2014
headlines Oakland County
headlines National
- This Los Angeles lawyer found her calling as a death doula
- ACLU and BigLaw firm use ‘Orange is the New Black’ in hashtag effort to promote NY jail reform
- Artificial intelligence tools for brief writing and analysis are a small firm litigator’s new best friend
- Baker McKenzie partner drops suit seeking IRS documents on partnership scrutiny
- Family members sue networks after learning of loved ones’ deaths by seeing bodies on TV
- Ex-BigLaw attorney once ‘consumed with remorse’ over $10M client theft sentenced in new scheme